metformin has been researched along with Eye Cancer, Retinoblastoma in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodowska, K | 1 |
| Theodoropoulou, S | 1 |
| Meyer Zu Hörste, M | 1 |
| Paschalis, EI | 1 |
| Takeuchi, K | 1 |
| Scott, G | 1 |
| Ramsey, DJ | 1 |
| Kiernan, E | 1 |
| Hoang, M | 1 |
| Cichy, J | 1 |
| Miller, JW | 1 |
| Gragoudas, ES | 1 |
| Vavvas, DG | 1 |
1 other study available for metformin and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Effects of metformin on retinoblastoma growth in vitro and in vivo.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Cell Proliferation; Gene Expression Re | 2014 |